We investigated if prenatal exposures to tobacco smoke lead to changes in mitochondrial DNA content (mtDNA) in cord serum and adversely affect newborns' health. Umbilical cord serum cotinine levels were used to determine in utero exposure to smoking. Cord serum mtDNA was measured by quantitative polymerase chain reaction analysis of the genes coding for cytochrome c oxidase1 (MT-CO1) and cytochrome c oxidase2 (MT-CO2). Log transformed levels of mtDNA coding for MT-CO1 and MT-CO2 were significantly higher among infants of active smokers with higher serum level of cotinine (p < 0.05) and inversely associated with gestational age (p = 0.08; p = 0.02). Structural equation modeling results confirmed a positive association between cotinine and MT-CO1 and2 (p < 0.01) and inverse associations with gestational age (p = 0.02) and IGF-1 (p < 0.01). We identified a dose-dependent increase in the level of MT-CO1 and MT-CO2 associated to increased cord serum cotinine and decreased gestational age.
Introduction
Smoking exposure has been shown to be associated with variation in mitochondrial DNA (mtDNA) content and mitochondrial dysfunction in lung tissue, buccal cells, and saliva of adult active smokers. Exposure to tobacco smoke is associated with an increase in buccal cell and salivary mtDNA content in a dose-dependent fashion, for both smokers and former smokers, when compared with people who never smoked Tan et al. 2008 ). Masayesva and colleagues also showed a persistent high level of mtDNA content in saliva samples several decades after smoking cessation, which is consistent with a compensatory mechanism to the long-term mtDNA damages caused by smoking (Polyak et al. 1998) . Less is known about how maternal tobacco smoking may affect mtDNA in the fetus. Smoking during pregnancy is known to have serious consequences to the health of newborns, including loss of mitochondrial functionality (Hackshaw et al. 2011; Hayashi et al. 2011) . Maternal smoking during pregnancy also is associated with placental mitochondrial dysfunction, which might contribute to restricted fetal growth by limiting energy availability in cells (Bouhours-Nouet et al. 2005) . The primary aim of this study is to further understand the relationship between maternal smoking and mtDNA.
MtDNA is present at extremely high levels (10 3 -10 4 copies per cell) in cells that are mostly homoplasmic (containing identical copies of MtDNA) at birth (Lightowlers et al. 1997) . The human mitochondrial genome is small (16.5 kb) and encodes 13 genes of respiratory chain proteins, 22 genes for transfer RNA (tRNA), and 2 genes for ribosomal RNA (rRNA) (Supplementary Figure S1 from MITOMAP 2013). The proper functioning of mtDNA depends on its integrity and also on the number of copies, suggesting that even slight alterations in DNA sequences could have profound effects (Lightowlers et al. 1997) . Moreover, altered mtDNA is associated with aging as well as smoking (Lee et al. 1998) .
Due to the error-prone nature of mitochondrial replication and repair machinery, mtDNA is extremely vulnerable to damage; exposures to external mutagens or reactive oxygen species (ROS) cause a higher rate of mutations in mtDNA than in nuclear DNA (Kang & Hamasaki 2002) . Evidence suggests that mtDNA damage from oxidative stress accumulates over time (Fliss et al. 2000) , further reducing the integrity of mtDNA (Croteau & Bohr 1997; Polyak et al. 1998) . To compensate for the decline of respiratory function, the cell increases the mtDNA content (Barrientos et al. 1997 ). Damage to mtDNA can cause injury to the respiratory chain, increasing production of ROS, thereby increasing mitochondrial mass and mtDNA content (Fukagawa et al. 1999; Lezza et al. 2001) . Smoking-related damage to respiratory chain function in lymphocytes is associated with measures of oxidative damage (Miro et al. 1999) . Smoking also inhibits mitochondrial enzyme activity in platelets and causes mitochondrial dysfunction in alveolar macrophages (Smith et al. 1993; Aoshiba et al. 2001) .
A secondary aim of this study is to further explore the relationship between maternal smoking, mtDNA, and birth outcomes (growth and gestational age). Exposure to maternal smoking is known to be associated with a number of adverse birth outcomes, including intrauterine growth restriction (IUGR) and preterm birth (PTB). PTB is defined as birth at less than 37 weeks of gestation. Increasingly, studies of 'late preterm' and 'early term' pregnancies are identifying serious adverse health consequences along the continuum of gestational ages below 39 weeks of pregnancy Vogt et al. 2011; Ruth et al. 2012) . IUGR occurs when fetal growth is small in proportion to gestational age. Maternal smoking, as measured by serum cotinine levels, has been associated with reduced weight, length, and head circumference at birth (Wang et al. 1997) . Reduced size at birth is related to reduced gestational age, IUGR, or both (Kramer et al. 2000) . PTB and reduced gestational age have been associated with maternal smoking (Windham et al. 2000) . IUGR has also long been associated with maternal smoking in pregnancy (Kramer et al. 1999; Aagaard-Tillery et al. 2008) . Increased mtDNA content has been found in placentas of newborns with an in utero diagnosis of IUGR and in the blood of women carrying IUGR fetuses (Lattuada et al. 2008; Colleoni et al. 2010) .
We hypothesized that in utero exposure to maternal smoking, quantified in ng/ml of cotinine, would lead to increased mtDNA content in cord blood of newborns and be associated with impaired neonatal well-being, as measured by growth and gestational age. Cotinine, a metabolite of nicotine, is used as an indicator of tobacco smoke exposure, including secondary smoke, because it is detectable for up to one week after the use of tobacco. The level of cotinine in the blood, saliva, and urine is proportionate to the amount of exposure to tobacco smoke. Specifically, cotinine has been shown to be a sensitive and specific indicator for maternal exposure to active and second-hand tobacco smoke. For these reasons, cotinine is widely used as biomarker of smoke exposure (Florescu et al. 2009; Mattes et al. 2014) .
Exposure to maternal smoking is also associated with a decrease of insulin-like growth factor 1 (IGF-1) in cord plasma and cord blood. IGF-1 is known to play a fundamental role in fetal development, impacting proliferation, differentiation, and morphogenic pathways. In utero decreases in IGF-1 have been linked to fetal growth impairment and reduced birth size (Pringle et al. 2005; Ingvarsson et al. 2007 ). Thus, we have sought to include umbilical serum IGF-1 as a potential mediator for the relationship between maternal smoking, mtDNA, and birth outcomes.
Materials and methods

Study population
Subjects were selected from the Baltimore Tracking Health Related to Environmental Exposures (THREE) Study, a cross-sectional study of deliveries at the Johns Hopkins Hospital in Baltimore MD, designed to determine cord blood levels of a number of environmental chemicals, along with their relationship to thyroid hormone status and birth outcomes Herbstman et al. 2007; Herbstman et al. 2008; Wells et al. 2011) .
We collected umbilical cord blood from a sample of women presenting at the Johns Hopkins Hospital for delivery of singleton births from 26 November 2004 to 16 March 2005. Two study personnel abstracted demographic information and biological measures from the maternal medical records, and a 10 % random sample was re-reviewed by study clinicians. Additional information was obtained from forms completed by the nursing staff at the time of delivery. Age, education, marital status, and parity were self-reported. Self-reported maternal race was also recorded because it appeared in the medical records as one of the three categories: African-American, Caucasian, and Asian. Smoking status was defined using the maternal medical record. Gestational hypertension (GHTN) was categorized as present when the medical record included the diagnoses of pregnancy-induced hypertension and/or preeclampsia.
There were 609 live births between November 2004 and March 2005. Of these, 597 were singleton births. We were able to collect cord blood for 341 of the singleton births, of which 41 were of insufficient quantity, leaving a total of 300 births eligible for the THREE study. Additionally, for this specific study, six births were excluded due to known major congenital anomalies, and one for an initial twin gestation, leaving a total of 293 study participants. Factors associated with insufficient blood volumes collected were PTB, low birth weight, being first born, and younger age of mother. Of these, 242 samples had sufficient serum volume for DNA isolation. However, high-quality DNA was only available for confirmatory quantitative analyses for 142 samples, and these are the subject of this report.
Umbilical cord and umbilical cord blood samples were collected immediately after birth and stored at 4 °C for less than 3 h before further processing. Once collected, umbilical cord and cord blood samples were placed in the Labor and Delivery Suite refrigerators. Within a few hours of birth, samples were collected and transported by study personnel to a laboratory at the Johns Hopkins Bloomberg School of Public Health for processing. Umbilical cord samples were flash frozen. Blood specimens were centrifuged at 1000 g for 15 min, and serum was aliquoted into 2-ml polypropylene cryovials. Tissue and blood samples were then stored at − 80 °C.
Frozen samples were transferred on dry ice to the Tobacco Exposure Biomarkers laboratory at the Centers for Disease Control in Atlanta for cotinine analyses while other aliquots were archived. A total of 286 samples had sufficient volume for measurement of cotinine, which was conducted using positive-ion atmospheric pressure chemical ionization tandem mass spectrometry as previously described (Bernert et al. 1997) .
We analyzed serum IGF-1 at the Bayview General Clinical Research Center using the Quantikine Human IGF-1 Immunoassay, a solid-phase ELISA that contains E. coli-expressed recombinant human IGF-1 (R&D Systems, Inc., Minneapolis, MN).
Human subjects
The study received approval from the Johns Hopkins Medicine Institutional Review Board and was determined to be HIPAA exempt. The IRB waived the requirement for informed consent because the collected biological samples would otherwise have been discarded and the sample collection constituted no more than minimal risk to the subjects. Strict procedures protected subject confidentiality and all data and specimens were anonymized. Members of a community advisory committee, who were selected for their specific knowledge, expertise, and focus on important child health concerns in Maryland, had the opportunity to learn about and comment on this study before it was conducted.
DNA isolation from umbilical cord and umbilical cord blood serum
Twenty five milligrams of umbilical cord were cut up into small pieces and homogenized with a TissueRuptor (Qiagen) in the presence of 200 μl of lysis buffer for 3 min, as per instructions in the DNeasy Blood & Tissue Kit (Qiagen). One mill liter of cord serum was obtained from each participant. Matched umbilical cord and umbilical cord serum samples were randomly sorted prior to DNA extraction to reduce batch-processing bias, followed by digestion with 50 µg/ml proteinase K (Boehringer Mannheim, Germany) in the presence of 1 % sodium dodecyl sulfate at 48 °C for 3 days, followed by phenol/chloroform extraction and ethanol precipitation and finally dissolved in 30 μl of LoTE (2.5 mmol/l EDTA and 10 mmol/l Tris-HCl) as previously described (Hoque et al. 2003) . A total of 242 samples had sufficient serum volume for DNA isolation. However, high-quality DNA from umbilical cord serum was only available for confirmatory quantitative analyses for 142 samples, and these are the subject of this report.
Quantitative polymerase chain reaction
To measure the mtDNA content, we performed real-time polymerase chain reaction (PCR) of regions coding for mitochondrial genes, cytochrome c oxidase1 (MT-CO1), and cytochrome c oxidase2 (MT-CO2). The normalized dosage of these two mitochondrial subunit genes reflects the variation of mtDNA content (Jiang et al. 2006; Masayesva et al. 2006) . A Perkin-Elmer/ABI 7900 thermocycler was used to perform real-time PCR amplification for β-actin and mtDNA regions for MT-CO1 and MT-CO2 as previously described (Jiang et al. 2005) . Primers were obtained from Invitrogen (Carlsbad, CA). The MT-CO1 region was amplified using forward primer 5′-TTCGCCGACCGTTGACTATTCTCT-3′ and reverse primer 5′-AAGATTATTACAAATGCATGGGC. MT-CO2 region amplification was done using forward primer 5′-CCCCACATTAGGCTTAAAAACAGAT-3V and reverse primer 5VTATACCCCCGGTCGTGTAGC-3V. β-Actin amplification was achieved using forward primer 5′-ACCCACACTGTGCCCATCTAC-3′ and reverse primer 5′-TCGGTGAGGATCTTCATGAGGTA-3′. All TaqMan probes (Applied Biosystems, Foster City, CA) were 5′-FAM and 3′-TAMRA labeled. MT-CO1 probe 6-FAM-AACGACCACATCTACAACGTTATCGTCAC-TAMRA and β-actin probe 6-FAM-ATGCCCTCCCCCATGCCATCC-TAMRA were used. Probe and primer combinations were designed to avoid amplification of pseudo genes, by performing BLAST analysis of primers and probes. PCR amplifications were carried out in buffer containing 16.6 mmol/l ammonium sulfate, 67 mmol/l Trizma, 2.5 mmol/l MgCl 2 , 10 mmol/l β-mercaptoethanol, 0.1 % dimethyl sulfoxide, 600 nmol/l each of forward and reverse primers, 200 nmol/l TaqMan probe, 0.6 unit of platinum Taq polymerase, and 2 % Rox reference dye. Five hundred picograms of DNA were used to amplify mitochondrial regions, whereas 10 ng were used to amplify β-actin, a single copy gene. The real-time PCR reactions were performed in triplicate for each gene. Standard amplification curves for MT-CO1, MT-CO2, and β-actin genes were obtained using JHU-O11 cell line DNA. Mitochondrial to nuclear DNA ratios were calculated by dividing the mtDNA signal for each gene by the corresponding β-actin signal.
Statistical analysis
For the umbilical cord serum analyses, we compared mtDNA coding for MT-CO1 and MT-CO2 levels between newborns born to maternal smokers vs. maternal non-smokers (by self-report) and, classified, according to the levels of cord blood serum cotinine levels. Levels > 10 ng/ml were considered 'high' or consistent with active smoking and levels < 1 ng/ml were considered 'low' or consistent with non-smoking. There was some difference in the classification of smoking by cotinine levels vs. the medical record; two mothers reporting smoking during pregnancy had infants whose cord serum cotinine levels were < 1 ng/ml (0.871 and 0.115 ng/ml). Five mothers not reporting smoking had infants with cord serum cotinine levels within the active smoking range (> 10 ng/ml). We evaluated mtDNA content in paired umbilical cord and cord serum samples from newborns exposed to very low levels of cotinine in utero (non-smokers n = 106; mean = 0.05 ng/ml) and newborns exposed to high levels of cord serum cotinine (active and passive smokers n = 36; mean = 12.1 ng/ml).
Because mtDNA coding for MT-CO1 and MT-CO2, as well as cotinine, was log-normally distributed, we log transformed them for statistical analyses and computed medians and geometric means rather than arithmetic means. Linear regression analyses were used to assess relationships between the natural log of mtDNA coding for MT-CO1 and MT-CO2 vs. both measures of smoking (the natural log of cotinine and self-reported smoking), as well as measures of maternal and neonatal health, namely: GHTN, pregnancy-related diabetes, gestational age, birth weight, length, and head circumference for gestational age (analyses were repeated without log transforming the levels of mtDNA coding for MT-CO1 and MT-CO2 with essentially the same results, not shown in this paper).
Bivariate data analyses were conducted to identify potential confounders for relationships among exposure: cotinine; intermediate outcomes: mtDNA coding for MT-CO1 and MT-CO2 and IGF-1; birth outcomes (gestational age, length, head circumference, and birth weight); and demographic variables.
First-generation multivariate regression modeling is an excellent tool to predict variance in a dependent variable, based on linear combinations of independent variables. However, when evaluating more complex relationships among variables in which variables other than the independent variable are, themselves, interrelated, first-generation models are not appropriate. As described in our results, this is the case for several important relationships that we studied which found both direct and indirect pathways that explain the relationships between smoking and birth outcomes. First-generation models fail to capture such indirect as well as direct pathways. Therefore, structural equation modeling (SEM) was used to assess complex interrelationships among exposures, outcomes, and potential confounders/ modifying factors. SEM, more commonly used in the social sciences, is a statistical tool that enables the construction of complex directed acyclic graphs for conceptualizing complex models and the use of regression analysis to test such models (Tu 2009 ). SEMs extend standard multiple regression techniques through a system of linear equations that define the statistical relationships among measured variables to allow for the evaluation of more complex relationships than more commonly employed multiple regression techniques. Covariates -like sex or race -can be incorporated into SEM analysis. SEM can be used to model not only direct effects, but also mediating effects, such as effects that occur when one variable affects another variable, which in turn affects a third. As described by Beran, et al., SEM modeling is straightforward but this methodology has some of the same limitations as the underlying multiple regression techniques that they incorporate (Beran & Violato 2010) . SEM provides a framework for statistical analysis that includes multivariate procedures, and has been used in other research to assess complex genetic and environmental relationships (Li et al. 2006) , complex physiological interactions (Dyson et al. 2015) , and even complex public opinion data (van der Linden et al. 2015) .
Stata version 13 was used to construct a hypothesized version of the graphical SEM and to perform statistical tests for direct and indirect effects, estimated parameters, and combinations of estimated parameters (StataCorp 2013). The SEM estimated the effect of exposure to maternal smoking (determined by umbilical cord serum cotinine levels as a continuous independent variable) on birth outcomes (gestational age and head circumference as continuous dependent variables). Levels of mtDNA coding for MT-CO1 and MT-CO2, separately, as well as umbilical cord serum IGF-1, were modeled as continuous intervening variables. Several possible confounding variables for these relationships were controlled for in the model as categorical variables: sex, maternal race (African-American), maternal age (< 18), prepregnancy body mass index (BMI) (underweight), prepregnancy BMI (obese), GHTN, parity (one or more prior pregnancy), and medical coverage (private insurance). Final models did not include maternal age, BMI (underweight), parity, or medical coverage. Parity had a slightly poorer fit than race (African-American) and its inclusion (in the place of race) would have led to similar conclusions. For all variables in the final model, we calculated both direct effects and total effects on birth outcomes. Direct effects were the coefficients of exogenous variables on dependent variables, conditional on all other variables in the equation. Total effects computed the coefficient of exogenous variables on dependent variables after accounting for all the simultaneity in the system. Total effects include not only direct but also indirect (mediating) effects.
Results
Among the 142 newborns included in this study, 78 were male and 64 were female. The 142 newborns included in this study were similar to all 300 babies in the THREE study cohort (Table S1 ) with respect to demographics, smoking status, and cotinine levels. Maternal age ranged from 14 to 40 years and paternal age from 14 to 43 years. Twelve mothers were < 18 years of age and 11 were > 35. The majority of mothers, 103 (72 %), were African-American, 30 (21 %) Caucasian, and 9 (6 %) Asian. This ratio was similar to the ratio of African-American babies in the entire 300-person study (69 %) and the hospital as a whole for that year (70 %). The average birth weight was 3193 g (SD 578 g), somewhat higher for African-Americans (3236 ± SD 548 g) than Caucasians (3101 ± SD 671 g) and Asians (3004 ± SD 581 g). These data reflect the unique demographics of the population delivering infants at this hospital during this time period and are not generalizable.
We found higher levels of mtDNA coding for MT-CO1 and MT-CO2 in cord blood serum DNA of newborns exposed to high cotinine levels when compared to newborns exposed to very low cotinine levels in cord serum (MT-CO1 p = 0.02, MT-CO2 p = 0.02), as can be seen in Figure 1 . The cord serum levels of MT-CO1 and MT-CO2 mtDNA were highly correlated (0.95), as can be seen in the scatter plots in Supplementary Figure S2 To evaluate the relationship between MT-CO1 and MT-CO2 and smoking, we assessed relationships with possible confounding variables (Tables 1a and 1b ). Log transformed levels of mtDNA coding for MT-CO1 and MT-CO2 were higher for male infants (MT-CO1 p = 0.006; MT-CO2 p = 0.008), for infants of mothers with prepregnancy BMI classified as obese (MT-CO1 p = 0.06 and MT-CO2 p = 0.07); for infants from pregnancies complicated by GHTN (MT-CO1 p = 0.05 and MT-CO2 p = 0.18); and for infants of parous mothers (women with at least one prior pregnancy) (MT-CO1 p = 0.07 and MT-CO2 p = 0.02). We did not observe associations between the values of mtDNA coding for MT-CO1 or MT-CO2 with maternal age, maternal diabetes, medical insurance status (a measure of socioeconomic status), BMI as a continuous variable, or infant birth weight, head circumference, and length. Cotinine (log transformed) values (Tables 1a and 1b) were, on the other hand, significantly higher in African-American mothers (p = 0.0002); women with public insurance (p < 0.0001); youngest mothers (< 18 years, p = 0.10); infants of obese mothers; and mothers with prior pregnancies (p = 0.08). Cotinine levels were lower among mothers > 35 years of age (p = 0.12). Maternal diabetes was not associated with cotinine (Table 1a ). There was little evidence for confounding given that no variables were associated with both MT-CO1 and MT-CO2 and cotinine. Multivariate models separately regressing cotinine on MT-CO1 and MT-CO2, controlling for infant sex, maternal parity, and Figure 1. (a and B) MT-CO1 and MT-CO2 levels in umbilical cord and umbilical cord serum from newborns exposed to very low levels of cotinine in utero -non-smokers (n = 106, geometric mean = 0.05 ng/ml); and babies exposed to cotinine in utero -active and passive smokers (n = 36, mean = 12.1 ng/ml). race, showed strong positive linear relationships between the natural logs of MT-CO1 and MT-CO2 and cotinine (p = 0.014 and p = 0.007, respectively). To evaluate possible relationships between maternal smoking, mtDNA, and birth outcomes, we evaluated relationships between birth outcomes and other variables (Tables 1b and 1c ). As shown in Table 1b , gestational age is strongly associated with birth weight, length, and head circumference and each of these three growth parameters is strongly correlated with all of the others. Cotinine is negatively associated with gestational age and all three growth measures, as well as IGF-1, and positively associated with MT-CO1 and MT-CO2. IGF-1 is positively correlated with all birth outcomes and negatively with cotinine. MT-CO1 and MT-CO2 are strongly correlated. Both are negatively correlated with gestational age.
Because gestational age is not only a birth outcome, but also a strong predictor of growth measures, we evaluated bivariate associations between exposures and potential modifying and confounding factors on growth measures, while controlling for gestational age (Table 1c) .
Reduced gestational age was most strongly associated with GHTN, serum cotinine levels, and MT-CO1 and MT-CO2 levels. Male babies had lower birth weight and length for gestational age. Cotinine levels were associated with reduced gestational age and smaller head circumference for gestational age. IGF-1 was associated with increased gestational age. The levels of mtDNA coding for MT-CO1 and MT-CO2 were negatively associated with gestational age and positively associated with head circumference (more strongly for MT-CO2). These associations with head circumference only appear after controlling for gestational age (Table 1b) suggesting that the head circumference is larger for gestational age with increasing MT-CO1 and MT-CO2 levels.
In an earlier publication , we found that delivery mode by C-section and maternal height were associated with head circumference; however, these variables were not associated with levels of mtDNA coding for MT-CO1, MT-CO2, nor with cotinine, and these data are not included nor were these variables included in models.
The final SEM models of mtDNA levels coding for MT-CO1 and MT-CO2 are shown in Figure 2 . The strength of statistical associations is shown giving the standardized adjusted regression coefficients for each path in models. Likelihood ratios and probabilities greater than chi-square were for each model, respectively, 19.96 and 0.28 and 18.43 and 0.43. Figure 2 demonstrates individual relationships among the variables included in SEM models; total relationships are summarized in Table 2 . As shown in Figure 2 , cotinine had direct positive associations with mtDNA coding for both MT-CO1 and MT-CO2. On the other hand, cotinine had negative associations with both gestational age and head circumference. Cotinine also had a negative association with IGF-1, which, in turn, had a direct positive association with head circumference. Figure 2 also shows how the SEM controls for potential confounding by maternal race, sex, and other variables. As would be expected, longer gestational age was associated with having a larger head circumference. The final results of SEM modeling are summarized in Table 2 , which displays the total (direct + indirect) non-standardized associations for key variables in the pathway from cotinine to gestational age -CO1 and (B) MT-CO2. figures show relationships between MT-CO1 and MT-CO2, with smoking (natural log of cotinine,ng/ml), IGF-1 (insulin-like growth factor-1), Htn, and birth outcomes -gestational age (days), and head circumference (cm). other variables controlled in final models were maternal prepregnancy BmI (obese), race (african-american), and sex (male). Diagrams illustrate standardized coefficients for each direct pathway, error terms, and standard deviations (in variable boxes). and birth weight, length, and head circumference. Summarizing direct and indirect effects together, cotinine had strong negative associations with IGF-1 (p < 0.01); strong positive associations with levels of mtDNA coding for both MT-CO1 and MT-CO2 (p < 0.01 and p < 0.001, respectively); and strong negative associations with both gestational age (p < 0.05) and head circumference (p < 0.05). IGF-1 had a strong positive total (direct + indirect) association with head circumference (p = 0.01). Levels of mtDNA coding for both MT-CO1 and MT-CO2 had a strong total direct + indirect associations with gestational age (− 3 days with each log increase in MT-CO1 and − 3.7 days with each log increase in MT-CO2, p < 0.05). For MT-CO1 and MT-CO2, there was evidence for an increase in head circumference (0.2 cm with each log increase in MT-CO1 and 0.3 cm with each log increase in MT-CO2, p = 0.08 and 0.09, respectively). More detailed SEM results can be seen in Table S2 .
Discussion
Our results show an increase of mtDNA coding for MT-CO1 and MT-CO2 in newborns whose mothers were smokers or exposed to second-hand smoke during pregnancy compared to newborns with non-smoking mothers.
Higher levels of mtDNA coding for MT-CO1 and MT-CO2 were associated with reduced gestational age. Because smoking is a known risk factor for reduced gestational age and intrauterine growth, we used SEM to dissect the interrelationships between smoking (as assessed by cotinine levels), abundance of mtDNA coding for MT-CO1 and MT-CO2, IGF-1, and birth outcomes. SEM confirmed that there are strong independent associations between cotinine exposure levels and higher levels of mtDNA coding for MT-CO1 and MT-CO2, which are in turn associated with reductions in gestational age. Therefore, it seems possible from these results that mtDNA content not only may be part of the pathway for smoking's negative effect on gestational age but may also, in itself, be involved with reduced gestational age. On the other hand, SEM did not find an independent effect of MT-CO1 and MT-CO2 copy number on IUGR, i.e. reduced birth weight, length, and head circumference for gestational age, but in our final SEM, there was some evidence for an association between MT-CO1 and MT-CO2 copy number and increased head circumference for gestational age. The final SEM shows also an association between cotinine and reduced levels of IGF-1, which is independently associated with head circumference but not gestational age. Table 2 . Interrelationships between umbilical cord serum cotinine (ng/ml, ln), MT-CO, and IGF-1 * (ng/ml, ln) levels and associations with gestational age (d) and head circumference (cm) by sem on the natural log of MT-CO1 and MT-CO2, Baltimore tHree study. note:Both sets of models control for: maternal BmI (obese), race (african-american), and sex as well as possible mediation by gestational hypertension. We have identified a potential pathway for cigarette smoke constituents' adverse effect on newborns involving a dose-dependent increase in mtDNA coding for MT-CO1 and MT-CO2 levels in cord blood serum linked to decreased gestational age. This result is consistent with Masayesva et al. (2006) who reported a dose-dependent association of smoking with an increase in mtDNA coding for MT-CO1 and MT-CO2 in saliva. Other studies show that smoking during pregnancy may lead to variations in the number of mtDNA copies and dysfunction of mitochondria on other tissues such as the placenta, and that there is an association with reduced gestational age. Some of these studies reported a negative correlation with the number of cigarettes per day and the mtDNA content in the placenta, hypothetically due to damages of the mtDNA replication and regulatory mechanisms by tobacco toxic chemicals (Bouhours-Nouet et al. 2005) . On the contrary, other studies report an increase of mtDNA content in IUGR placenta possibly as a compensatory mechanism for the decline of respiratory function due to smoke's damages (Barrientos et al. 1997; Lattuada et al. 2008) . Unfortunately, these studies have a limited number of participants and their results besides being contradictory are inconclusive.
SEM results also suggest the implication of a second pathway involving IGF-1 and resulting in decreased growth (head circumference) for gestational age. Earlier studies have associated smoking with reduced levels of IGF-1 and reduced birth size (Pringle et al. 2005; Ingvarsson et al. 2007) . Ours is the first to evaluate these relationships with a SEM that assessed possible exposure and intermediate pathway interactions that may explain some of the deleterious effects caused by prenatal exposure to tobacco smoking. Additional studies will be needed to confirm these findings.
Prenatal exposure to tobacco smoke causes mutagenic and oxidative damage that leads to respiratory infections, asthma, allergies, and neurobehavioral complications. (Castles et al. 1999; Keohavong et al. 2005; Zalacain et al. 2006; Llaquet et al. 2010; Burke et al. 2012; Kilic et al. 2012; Lee et al. 2012; Jedrychowski et al. 2013) . Epidemiological and molecular studies reported also a possible increase in risk of childhood cancer (brain tumors and acute lymphoblastic leukemia in particular) in association with prenatal exposure to tobacco smoke, although this association is still controversial (Brooks et al. 2004; Bocskay et al. 2005; Ng et al. 2006; Ortega-García et al. 2010; Barrington-Trimis et al. 2013; Milne et al. 2013; Bhattacharya et al. 2014 ). Since the oxidative phosphorylation mechanism is fundamental in aerobic metabolism, it is not surprising that exposure to oxidative or mutagenic agents may damage the respiratory chain and disrupt oxidative phosphorylation.
Studies report that mtDNA is more susceptible to oxidative and mutagenic damage compared to the nuclear genome (Marcelino & Thilly 1999; Lee et al. 2012 ). This high susceptibility to damage may be linked to the absence of histones, to the error-prone nature of the mitochondrial replication and repair machinery, as well as to the production of a large amount of ROS and the proximity of accumulated toxic xenobiotics to mtDNA (Penta et al. 2001; Kang and Hamasaki 2002) . MtDNA damage reduces the functionality of the respiratory chain and increases the production of ROS, giving rise to a vicious circle. Thus, cells increase mitochondrial mass and mtDNA content in order to compensate for the decreased production of energy (Smith et al. 1993; Banzet et al. 1999; Aoshiba et al. 2001; Masayesva et al. 2006; Armani et al. 2009 ). This mechanism of response to the action of genotoxic agents or oxidants, such as smoking, could be an indicator of altered mitochondrial function, and explain the increase in mtDNA content in cord serum.
We found levels of mtDNA coding for MT-CO1 and MT-CO2 were associated with cotinine and lower gestational age. There are several ways to explain this association. Maternal smoking may be affecting the functionality of the respiratory chain in utero, via mutational or oxidative damage directly to fetal mtDNA and/or via alternative effects on oxygen delivery. Tobacco smoke contains several oxidative and mutagenic substances that affect the functionality of the respiratory chain or lead to mutations in mtDNA (Smith et al. 2003) . This reduction in gestational age, while small, is a significant effect on the fetus across the population. Pregnant smokers have elevated oxygen radical injury that can be measured by breath ethane, produced by peroxidation of omega-3-fatty acids. Schwartz and colleagues showed that ethane was elevated in pregnant smokers when compared to pregnant non-smokers, suggesting that cigarette smoking is therefore pro-oxidant (Schwarz et al. 1995 ). Longo published one of the several studies reporting associations between smoking during pregnancy and decreased oxygen delivery to the fetus (Longo 1976) . Of the numerous compounds in cigarette smoke, there are three prime candidates for producing this effect: nicotine, of which cotinine is a stable metabolite, carbon monoxide, and cyanide. Nicotine and carbon monoxide are found in higher concentrations in cord blood than in maternal blood, as is the metabolite of cyanide, thiocyanate. Nicotine is believed to act by producing vasospasm resulting in poorer placental perfusion (Suzuki et al. 1971; Lehtovirta & Forss 1978) while carbon monoxide and cyanide are both direct respiratory poisons (Longo 1976; Pettigrew et al. 1977) . In our study, cotinine is a direct measure of nicotine and also is a marker for other harmful constituents of tobacco smoke. Additional studies will be required to elucidate how maternal smoking may be affecting the functionality of the respiratory chain in utero, via mutational or oxidative damage directly to fetal mtDNA and/or via alternative effects on oxygen delivery and energy metabolism.
The role of mitochondria in energy production is critically important for placental function during embryonic development. Impaired mitochondrial function has been shown to lead to low birth weight in mice (Wakefield et al. 2011 ). Other studies have described the association between mtDNA content and mitochondrial protein mutations with IUGR (Lattuada et al. 2008; Muralimanoharan et al. 2012) . Our SEM results, showing IGF-1 had a direct positive association with levels of mtDNA coding for MT-CO1 and MT-CO2, contribute to accumulating evidence that mitochondria play a central role in fetal metabolic programming (Morten et al. 2005) . While this paper was under revision, two manuscripts were published providing more evidence of the dynamic relationship between prenatal exposure, mtDNA content, IUGR, and metabolic programming in utero (Poidatz et al. 2015) . Effective fetal growth is dependent on the transport of nutrients from the placenta to the fetus, which requires ATP, insulin, and several growth factors, including IGF-1. Changes in mitochondrial morphology detected with high throughput imaging suggest that placental mitochondrial function is a regulator of fetal and placental growth (Chiaratti et al. 2015) . However, our results suggest that mitochondrial function may be linked to adverse birth outcomes via earlier gestational age rather than via IUGR. Nonetheless, the accumulating evidence suggests that metabolic programming by prenatal exposures is mediated by alterations in mitochondrial structural alterations, which in turn lead to changes in mitochondrial function and content to maintain homeostasis in energy production. Together, this evidence indicates that mitochondria play an important role in the fetal metabolic response to adverse prenatal exposures and may be at the mechanistic center of pathways linking these exposures to adverse health outcomes throughout the life course (Marzetti et al. 2013 ).
This study was limited by the availability of umbilical cord blood serum of enough quality and quantity to extract circulating fetal DNA that could be used for downstream analyses. For the same reason, it was not feasible to compare the quantity of mtDNA with mitochondrial mass. Another limitation of the study was that maternal blood was not collected during the study, negating the possibility of establishing a link between maternal and fetal serum cotinine levels. Moreover, other environmental and hereditary factors may influence the exposure to damaging agents and alter the mitochondrial response to tobacco. Notwithstanding these limitations, the observed effects are consistent with prior observations made by several investigators, providing biological plausibility for the results we are reporting.
